Lessee, Operating Lease, Liability, to be Paid, Year One of EUPRAXIA PHARMACEUTICALS INC. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
EUPRAXIA PHARMACEUTICALS INC. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • EUPRAXIA PHARMACEUTICALS INC. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 31 Dec 2025 was $85,312, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

EUPRAXIA PHARMACEUTICALS INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $85,312 +$10,822 +15% 31 Dec 2025 40-F 13 Mar 2026 2025 FY
Q4 2024 $74,490 +$13,710 +23% 31 Dec 2024 40-F 20 Mar 2025 2024 FY
Q4 2023 $60,780 31 Dec 2023 40-F 01 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.